poloxalene has been researched along with tetronic 701 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brophy, L; Merisko-Liversidge, E; Steel, V; Uhl, J; Watrous-Peltier, N | 1 |
| Davis, SS; Illum, L; Mak, E; Müller, RH; West, P | 1 |
| Maassen, S; Mehnert, W; Müller, RH; Weyhers, H | 1 |
| Davis, SS; Garnett, MC; Illum, L; Neal, JC; Stolnik, S | 1 |
4 other study(ies) available for poloxalene and tetronic 701
| Article | Year |
|---|---|
Direct suppression of phagocytosis by amphipathic polymeric surfactants.
Topics: Animals; Cells, Cultured; Ethylenediamines; Liver; Macrophages; Male; Mice; Phagocytosis; Poloxalene; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Surface-Active Agents | 1992 |
The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer--poloxamine 908.
Topics: Animals; Colloids; Ethylenediamines; Kidney; Liver; Lung; Microspheres; Myocardium; Poloxalene; Polyethylene Glycols; Polymers; Polystyrenes; Rabbits; Spleen | 1987 |
Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407.
Topics: Drug Carriers; Ethylenediamines; Humans; Lipid Metabolism; Lipids; Mononuclear Phagocyte System; Phagocytes; Poloxalene; Polyethylene Glycols; Surface-Active Agents | 1996 |
Modification of the copolymers poloxamer 407 and poloxamine 908 can affect the physical and biological properties of surface modified nanospheres.
Topics: Animals; Ethylenediamines; Female; Liver; Microspheres; Poloxalene; Polyethylene Glycols; Rats; Rats, Wistar; Surface Properties; Tissue Distribution | 1998 |